The global vertigo treatment market has witnessed significant growth in recent years, driven by an increase in vertigo cases among adults and the elderly, heightened awareness of inner ear disorders, and the availability of effective treatments. According to Allied Market Research, the vertigo treatment market was valued at $1.3 billion in 2021 and is projected to reach $1.9 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031.
Understanding Vertigo
Vertigo is characterized by a sensation of spinning or loss of balance, even when stationary. Common causes include head injuries, benign paroxysmal positional vertigo (BPPV), vestibular neuronitis, Ménière’s disease, and certain medications like cisplatin. Symptoms often encompass nausea, vomiting, tinnitus (ringing in the ears), motion sickness, headaches, and difficulty focusing.
Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/A12485
Vertigo Treatment Market Growth Factors
Several factors contribute to the expansion of the vertigo treatment market:
- Rising Prevalence of Vertigo: An increasing number of individuals are experiencing vertigo, particularly among the aging population. Studies indicate that approximately 40% of the U.S. population experiences vertigo at least once in their lifetime.
- Advancements in Treatment Therapies: Innovations such as the Canalith repositioning procedure, also known as the Epley maneuver, have been developed to treat BPPV more effectively. This therapy, introduced by the Mayo Clinic in October 2020, has contributed to market growth.
- Availability of Over-the-Counter (OTC) Medications: The accessibility and affordability of OTC medications have made vertigo treatments more attainable, further propelling market expansion.
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/purchase-enquiry/A12485
Vertigo Treatment Market Segmentation
The vertigo treatment market is segmented based on type, treatment, distribution channel, and region.
- By Type:
- Peripheral Vertigo: This segment accounted for the largest market share in 2021 and is expected to continue its dominance, driven by the high prevalence of BPPV.
- Central Vertigo: Although less common, this segment is anticipated to experience significant growth due to increasing cases related to brainstem and cerebellum issues.
- By Treatment:
- Antihistamines: Dominating the market in 2021, antihistamines are favored for their efficacy in treating vertigo symptoms such as nausea and vomiting.
- Anticholinergics: These are used in specific cases but hold a smaller market share compared to antihistamines.
- Others: This category includes antibiotics, benzodiazepines, and antidepressants, utilized based on individual patient needs.
- By Distribution Channel:
- Drug Stores and Retail Pharmacies: In 2021, this segment led the market, attributed to the widespread availability of vertigo medications and the increasing number of patients seeking treatment.
- Online Providers: This segment is projected to witness considerable growth, reflecting the rising trend of purchasing medications online.
Regional Insights
North America held the largest market share in 2021, primarily due to the high prevalence of vertigo and a substantial geriatric population. Europe followed, benefiting from increased awareness and a broad range of available treatments. The Asia-Pacific region is expected to exhibit notable growth, driven by a rising elderly population and unmet medical needs.
Key Players in the Vertigo Treatment Market
The vertigo treatment market comprises several prominent pharmaceutical companies, including:
- Amneal Pharmaceuticals Ltd.
- AstraZeneca Plc.
- Epic Pharma, LLC
- GlaxoSmithKline Plc.
- F. Hoffmann-La Roche AG
- Intas Pharmaceuticals Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Ltd.
- Viatris (Mylan N.V.)
These companies play a crucial role in developing and distributing medications that address various vertigo conditions.
The vertigo treatment market is poised for steady growth, driven by an increasing prevalence of vertigo, advancements in treatment options, and greater awareness of inner ear disorders. As the global population continues to age, the demand for effective vertigo treatments is expected to rise, presenting opportunities for pharmaceutical companies to innovate and expand their offerings.
Procure Complete Report: https://www.alliedmarketresearch.com/vertigo-treatment-market/purchase-options
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
